Is BRLI a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

789 people get BRLI articles and Market Currents by email alert.

Get email alerts on BRLI »

HEADLINES:

Growth Stocks Portfolio That Can Outperform The Market By A Big Margin
Arie Goren • Mon, May 20 • 5 Comments
BioReference Laboratories, Inc to Speak at the UBS Global Healthcare Conference

GlobeNewswire (May 15, 2013)
Super-Fast Growing Mid-Cap Growth Stocks With Explosive Returns
Chuck Carnevale • Fri, May 10 • 60 Comments
Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference

GlobeNewswire (May 8, 2013)
10 Piotroski Stocks To Beat The Market
Arie Goren • Fri, Apr 19 • 4 Comments
Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without Merit

GlobeNewswire (Apr 12, 2013)
Why Bio-Reference Laboratories Is A Dangerous Investment
StockBaller • Thu, Apr 11 • 12 Comments
5 Reasons Why Bio-Reference Laboratories Is A Solid Stock
Jae Jun • Mon, Apr 1 • 4 Comments
10 Stocks To Consider In An Extended Market
Alan Brochstein • Sun, Mar 17 • 6 Comments
Bio-Reference: Claims Don't Match The Evidence
The Street Sweeper • Mon, Mar 4 • 2 Comments
Bio-Reference Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, Feb 28
Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting in Record First Quarter Revenue and Earnings

GlobeNewswire (Feb 28, 2013)
Bio-Reference Laboratories, Inc. Will Offer Non-Invasive Prenatal Testing (NIPT) From Natera

GlobeNewswire (Feb 27, 2013)
Bio-Reference Laboratories, Inc. Announces Earnings Will be Reported on February 28, 2013, Will Reflect Change in Presentation of Revenues and Bad Debt to Comply With Accounting Standards Update Topic 954; No Effect on Net Income or EPS From Update Implementation

GlobeNewswire (Feb 25, 2013)
A Portfolio For The Next Market Crash
Martin Lowy • Fri, Feb 15 • 37 Comments
Biotech Proper Is Overbought, Time To Look At Alternatives
Austrolib • Mon, Feb 4 • 6 Comments
9 High-Growth Healthcare Stocks With Bearish Stock Trends
Kapitall • Wed, Dec 19, 2012 • 4 Comments
Bergen County-based Bio-Reference Donates $100,000 to Hurricane Sandy New Jersey Relief Fund

PR Newswire (Dec 18, 2012)
Bio-Reference Laboratories' CEO Discusses F4Q 2012 Results - Earnings Call Transcript
Thu, Dec 6, 2012
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane Sandy

Business Wire (Dec 6, 2012)

To learn more about Seeking Alpha Pro, click here.

Why Bio-Reference Laboratories Is A Dangerous Investment
StockBaller • Thu, Apr 11 • 12 Comments
5 Reasons Why Bio-Reference Laboratories Is A Solid Stock
Jae Jun • Mon, Apr 1 • 4 Comments
Bio-Reference: Claims Don't Match The Evidence
The Street Sweeper • Mon, Mar 4 • 2 Comments
Bio-Reference Labs: Stand-Out Stock With High-Growth Potential
David Zanoni • Sun, Sep 23, 2012 • 9 Comments
Deep Discount Strategy For Bio-Reference Laboratories - Initial Price Target
Dustin Small • Wed, Aug 1, 2012 • 6 Comments
Bio-Reference: Defying The Market And On Its Way Back Up, With Good Reason
Kinetic Investments • Thu, Dec 15, 2011 • 10 Comments
Has The Recent Attack On Bio-Reference Laboratories Left Shares Oversold?
Kinetic Investments • Sun, Nov 20, 2011 • 7 Comments
Bio-Reference: Loads Of Dirty Laundry
The Street Sweeper • Sun, Nov 13, 2011 • 5 Comments
Is Bio-Reference Laboratories As Healthy As It Seems?
The Street Sweeper • Wed, Nov 2, 2011 • 1 Comment
Bio-Reference Labs: Sustainable Long-Term Growth
Steven M. Rogé • Wed, Aug 10, 2011 • 3 Comments
Bio-Reference Labs: Just What the Doctor Ordered
James Hale • Thu, Jun 7, 2007

Growth Stocks Portfolio That Can Outperform The Market By A Big Margin
Arie Goren • Mon, May 20 • 5 Comments
Super-Fast Growing Mid-Cap Growth Stocks With Explosive Returns
Chuck Carnevale • Fri, May 10 • 60 Comments
10 Piotroski Stocks To Beat The Market
Arie Goren • Fri, Apr 19 • 4 Comments
10 Stocks To Consider In An Extended Market
Alan Brochstein • Sun, Mar 17 • 6 Comments
A Portfolio For The Next Market Crash
Martin Lowy • Fri, Feb 15 • 37 Comments
Biotech Proper Is Overbought, Time To Look At Alternatives
Austrolib • Mon, Feb 4 • 6 Comments
9 High-Growth Healthcare Stocks With Bearish Stock Trends
Kapitall • Wed, Dec 19, 2012 • 4 Comments
7 Undervalued, Highly Shorted Stocks With Strong Sources Of Profitability
Kapitall • Fri, Nov 30, 2012 • 2 Comments
World Demographics: Embracing The Gracious Aging World
Nick Chiu • Fri, Nov 16, 2012 • 15 Comments
Cramer's Lightning Round - Dunkin' Donuts Declares The End Of The Coffee Wars (11/1/12)
SA Editor Miriam Metzinger • Fri, Nov 2, 2012
Earnings Analysis: Quest Diagnostics Inc.
CapitalCube • Thu, Oct 18, 2012
QE3 And The Buy-Low Sell-High Portfolio
Martin Lowy • Mon, Oct 8, 2012
Update: 8 High-Growth Healthcare Stocks With Strong Sources Of Profitability
Kapitall • Tue, Jul 17, 2012
9 Highly Shorted, Undervalued Stocks With Positive Receivable Trends
Kapitall • Sun, Jun 3, 2012
9 Undervalued Small-Cap Stocks Hoarding Cash For The Right Opportunities
ZetaKap • Fri, May 25, 2012
Coffee Stock Jitters? Consider These 9 Alternatives
Stocks & Shares • Mon, Mar 26, 2012 • 1 Comment
Bio Reference Labs, Quest Diagnostics Inc., Laboratory Corp. Of America: Diagnosis Profits
Chuck Carnevale • Mon, Mar 5, 2012 • 6 Comments
16 Rallying Healthcare Stocks Being Sold By Hedge Funds
Kapitall • Tue, Feb 21, 2012
8 Safe Alternative Investments To Gilead
Stocks & Shares • Mon, Feb 20, 2012 • 1 Comment
10 Highly Shorted, Rallying Stocks With Strong Sources Of Profitability
Kapitall • Thu, Feb 2, 2012

Bio-Reference Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, Feb 28
Bio-Reference Laboratories' CEO Discusses F4Q 2012 Results - Earnings Call Transcript
Thu, Dec 6, 2012
Bio-Reference Laboratories' CEO Discusses Q3 Results - Earnings Call Transcript
Thu, Aug 30, 2012 • 3 Comments
Bio-Reference Laboratories Inc. F3Q09 (Qtr End 07/31/09) Earnings Call Transcript
Wed, Sep 2, 2009
Bio-Reference Laboratories F1Q09 (Qtr End 1/31/09) Earnings Call Transcript
Thu, Mar 5, 2009
Bio-Reference Laboratories, Inc. Q4FY08 Earnings Call Transcript
Thu, Dec 18, 2008
Bio-Reference Laboratories, Inc Q3 2008 Earnings Call Transcript
Wed, Sep 10, 2008
Bio-Reference Laboratories, Inc. F2Q08 (Qtr End 4/30/08) Earnings Call Transcript
Thu, Jun 5, 2008

BioReference Laboratories, Inc to Speak at the UBS Global Healthcare Conference

GlobeNewswire (May 15, 2013)
Bio-Reference Laboratories, Inc. to Speak at the Bank of America Merrill Lynch Health Care Conference

GlobeNewswire (May 8, 2013)
Bio-Reference Laboratories, Inc. Responds to an Employee Wrongful Termination Suit Filed Against it as Baseless and Without Merit

GlobeNewswire (Apr 12, 2013)
Bio-Reference Laboratories, Inc. Announces Strong Growth Resulting in Record First Quarter Revenue and Earnings

GlobeNewswire (Feb 28, 2013)
Bio-Reference Laboratories, Inc. Will Offer Non-Invasive Prenatal Testing (NIPT) From Natera

GlobeNewswire (Feb 27, 2013)
Bio-Reference Laboratories, Inc. Announces Earnings Will be Reported on February 28, 2013, Will Reflect Change in Presentation of Revenues and Bad Debt to Comply With Accounting Standards Update Topic 954; No Effect on Net Income or EPS From Update Implementation

GlobeNewswire (Feb 25, 2013)
Bergen County-based Bio-Reference Donates $100,000 to Hurricane Sandy New Jersey Relief Fund

PR Newswire (Dec 18, 2012)
Bio-Reference Laboratories, Inc. Announces Record Revenues and Earnings for Fourth Quarter and for Full Fiscal Year Despite Effects of Hurricane Sandy

Business Wire (Dec 6, 2012)
Lightning Round: Dunkin Donuts, Yahoo!, Netflix & More

at CNBC.com (Nov 1, 2012)
Bio-Reference to Launch Laboratorio Buena Salud, The First Nationwide Full-Service Hispanic Laboratory

PR Newswire (Oct 10, 2012)
Health Care Sector Wrap

at Fox Business (Aug 30, 2012)
First Solar, Sears Holdings Among Stocks Down on Above-average Volume Thursday

at Fox Business (Aug 30, 2012)
Bio-Reference Laboratories, Inc. Reports Best Quarterly Revenues and Earnings in Corporate History with 25% Increase in Earnings Per Share

Business Wire (Aug 30, 2012)
Stocks to Watch: Stocks to watch Thursday: Pandora, Greenway, Culp

at MarketWatch.com (Aug 30, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
Health Care Sector Wrap

at Fox Business (Aug 16, 2012)
GenPath Diagnostics of BioReference Laboratories, Inc. Awarded 2012 Clinical Diagnostics Company of the Year Award by Frost & Sullivan

Business Wire (Jun 26, 2012)

BRLI vs. ETF Alternatives

Company Description

We believe that we are the largest independent regional clinical laboratory servicing the greater New York metropolitan area. We offer a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of... More

Sector: Healthcare

Industry: Medical Laboratories & Research

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Monday, May 13, 3:56 PM The 25 most heavily shorted stocks (as a percent of float) in the S&P 1500 as of the end of April are up 6.75% in May, trouncing the S&P's 2.33% gain, according to Bespoke - and this doesn't include Tesla, up 57% with 40% of its float shorted, but not a S&P 1500 member. The top 5 heavily shorted: BTH, QCOR, CSTR, BRLI, SPPI. The rest in another post. 4 Comments
Thursday, February 28, 12:33 PM Bio-Reference Laboratories (BRLI +5.8%) shrugs off a negative article in The Street Sweeper yesterday to trade higher in spite posting a mixed FQ1 earnings report. The company beat on a per share basis but missed on its top line consensus as revenue was impacted from hurrican Sandy. Going forward the company reaffirms its guidance for FY13, still expecting net revenues to increase more than 15% and net income to increase by approximately 20%. Comment! [Healthcare, Earnings, On the Move]
Thursday, February 28, 12:05 AM Notable earnings before Thursday’s open: AIXG, AWR, BDBD, BKS, BRLI, BRY, CHS, CTRX, CVC, DANG, DPZ, GMXR, GTLS, HK, IRDM, IRM, ISIS, KSS, LKQ, MCGC, MTG, NIHD, OCN, PKT, RDC, RNO, SDRL, SHLD, TD, TTI, VRX, WNR, WPX, WWE Comment! [Earnings]
Wednesday, February 27, 5:30 PM Notable earnings before Thursday’s open: AIXG, AWR, BDBD, BKS, BRLI, BRY, CHS, CTRX, CVC, DANG, DPZ, GMXR, GTLS, HK, IRDM, IRM, ISIS, KSS, LKQ, MCGC, MTG, NIHD, OCN, PKT, RDC, RNO, SDRL, SHLD, TD, TTI, VRX, WNR, WPX, WWE Comment! [Earnings]
Wednesday, February 27, 3:24 PM Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street Sweeper. The gist of the article says that the company is likely to be faced with a flood of denials from some of the largest health insurance companies in the country, and that growth projections are overly optimistic. 3 Comments [Healthcare, On the Move]
Thursday, December 6, 2012, 3:35 PM Bio-Reference Laboratories (BRLI +5%) moves up after reporting a largely in-line FQ4, but a 16% Y/Y jump in total revenue. Net profit also rose 23%, as the company again recorded strong revenue growth, despite the impact of Hurricane Sandy on the Northeast regional provider of diagnostic testing for physicians. Revenue per patient rose 4% in the latest quarter, while the number of patients served rose 12%. 1 Comment [Healthcare, Earnings, On the Move]
Thursday, December 6, 2012, 8:38 AM Bio-Reference Laboratories (BRLI): FQ4 EPS of $0.46 in-line. Revenue of $176.1M (+16% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Thursday, August 30, 2012, 2:40 PM Shares of Bio-Reference Laboratories (BRLI -9.5%) get hammered, despite its FQ3 beating on its bottom line earlier today. Net earnings rose 25% Y/Y, as the clinical-testing company's streak of double-digit revenue growth continued, but investors appear to be taking advantage of near 52-week highs to lock in profits as sales growth shows signs of stagnating. 1 Comment [Healthcare, Earnings, On the Move]
Thursday, August 30, 2012, 8:45 AM Bio-Reference Laboratories (BRLI): Q2 EPS of $0.45 beats by $0.03. Revenue of $172.3M (+16.4% Y/Y) in-line. Shares +4.4% premarket. (PR) 1 Comment [Earnings, Healthcare, On the Move]
Thursday, August 30, 2012, 12:05 AM Notable earnings before Thursday’s open: BRLI, CIEN, TD Comment! [Earnings]
Wednesday, August 29, 2012, 5:30 PM Notable earnings before Thursday’s open: BRLI, CIEN, TD 1 Comment [Earnings]
Tuesday, June 12, 2012, 11:47 AM Bio-Reference Labs (BRLI +6.5%) pops after BofA Merrill Lynch ups the shares to Buy, citing how the returns on the commercialization of its high-end tests in a number of high-growth specialty niches are starting to bear fruit. Additionally, reimbursement headwinds and new billing codes are more likely to disproportionately impact small players, which gives BRLI the opportunity to capture market share. Comment! [Healthcare, On the Move]
Thursday, June 7, 2012, 8:42 AM Bio-Reference Laboratories (BRLI): FQ2 EPS of $0.33 beats by $0.01. Revenue of $163.4M (+18.7% Y/Y) beats by $3M. (PR) Comment! [Earnings, Healthcare]
Thursday, March 1, 2012, 11:25 AM Bio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped 23% Y/Y on double digit sales growth as the clinical-testing company's patient count has risen and its share of complex, non-routine testing services continues to grow. Comment! [Healthcare, Earnings, On the Move]
Thursday, March 1, 2012, 8:48 AM Bio-Reference Laboratories (BRLI): FQ1 EPS of $0.26 beats by $0.05. Revenue of $150M (+23% Y/Y) beats by $7M. (PR) Comment! [Earnings, Healthcare]
Thursday, December 8, 2011, 10:13 AM Bio-Reference Laboratories (BRLI +5.4%) gains after reporting Q3 results that beat estimates by a slim margin. The embattled firm says it expects to increase net revenues by more than 15% and net income by around 20% in 2012. Comment! [On the Move]

dowjobber
$BRLI Rumor from Fly on the Wall on May 22. "theflyonthewall.com: Rumor: Bio-Reference Labs moves up on renewed takeover chatter"
Fri, 11:46 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

SKS1586
Reduced or sold $BRLI, $AERL, $DLB, $EXPD, $INTC, $KO, $MHFI. $CY, $WPRT to protect profit (>10%) & create CASH
Mar 1, 3:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

SKS1586
Bought-$VMW,$EMC,$CY,$CSCO,$INTC,$MSFT,$IBM,$CLF,$CCJ,$FCX,$SCCO,$SWC,$WFC,$CJES,$ECA,$DPM,$BP,$MRK,$UNH,$BRLI,$KO,$SYY,$CHRW,$VOD,$JOY,$HMC
Feb 25, 4:53 PM
Reply (15)

• !Report Abuse
View all 15 replies
SKS1586: andyk80: Mr Market is listening to you & following your thought of bounce, with uptick in all the Futures @ this moment.
Feb 25, 8:19 PM
• !Report Abuse
SKS1586: I diversified my buys in all the sectors today. My unhappy buys are Platinum ($SWC), Copper ($SCCO, $FCX), Energy ($BP,$DVN,$ECA,$DPM,$KBR).
Feb 25, 8:26 PM
• !Report Abuse
Add a reply...

140 characters

Brennan Basnicki
Great Day! Long $AAU $NIHD $CLF $WLT $ACI $ANR $KGC $FSLR $RDN $LOW $HAL $APC $BRLI, Short $GPS $PM
Jan 22, 8:36 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Lululemon ($LULU), Bio-Reference ($BRLI), G-III Apparel ($GIII), Coca Cola Femsa ($KOF), & Grupo ($ASR) rose Thursday on unusual volume.
12/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
From long-term chart, Bio-Reference Laboratories (BRLI) seem to have consistently yielded 20-50% annually. http://yhoo.it/SMTHcn;c=
10/5/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Cabela's (CAB), Altisource Portfolio (ASPS), Group 1 Automotive (GPI), Bio-Reference (BRLI), & MasTec (MTZ) rose Thursday on unusual volume.
10/5/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/UcV2Mp Trading ideas for Aug 30th: $CIEN, $TIVO, $OVTI, $BRLI. $VXX $UVXY $TZA, $FAZ
8/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

freefdawatchlist
http://bit.ly/UcV2Mp Premarket watch: All three heavily shorted stock $OVTI, $BRLI, $CIEN, ready to jump 20% on surprise beat.
8/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
Cyberonics (CYBX), Genesco (GCO), Sunoco Logistics (SXL), Gordmans Stores (GMAN), & Bio-Reference Labs (BRLI) rose Wednesday on unusual vol.
8/29/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

SKS1586
Bought-$VMW,$EMC,$CY,$CSCO,$INTC,$MSFT,$IBM,$CLF,$CCJ,$FCX,$SCCO,$SWC,$WFC,$CJES,$ECA,$DPM,$BP,$MRK,$UNH,$BRLI,$KO,$SYY,$CHRW,$VOD,$JOY,$HMC
Feb 25, 4:53 PM
Reply (15)

• !Report Abuse
View all 15 replies
SKS1586: andyk80: Mr Market is listening to you & following your thought of bounce, with uptick in all the Futures @ this moment.
Feb 25, 8:19 PM
• !Report Abuse
SKS1586: I diversified my buys in all the sectors today. My unhappy buys are Platinum ($SWC), Copper ($SCCO, $FCX), Energy ($BP,$DVN,$ECA,$DPM,$KBR).
Feb 25, 8:26 PM
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Kenexa (IBM), Movado Group (MOV), Bio-Reference Laboratories (BRLI), Calumet Specialty (CLMT), & Syntel (SYNT) rose Monday on unusual vol.
8/27/12
Reply (1)

• !Report Abuse
View all 1 replies
Tom in Texas: Long CLMT - A specialty refiner with a healthy dividend.
8/27/12
• !Report Abuse
Add a reply...

140 characters

BRLI Bio-Reference Laboratories, Inc.

BRLI

Bio-Reference Laboratories, Inc.